Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fabrazyme PK During Hemodialysis in Fabry Disease
NCT00312767Phase 4Withdrawn
- Sponsor
- Sanofi
- Start
- Apr 2006
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Planned start Apr 2006; status: withdrawn.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00312767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312767.